Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

You are here: Home / Statistics / Comparative statistics by registry

Comparative statistics by cancer registry

Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site

(Incheon, South Korea, 1997-2001 cases followed-up until 2002)

Click on cancer site (ICD-10 code) for comparison

			%		No. of excluded cases					Included cases
Site	ICD-10	Total registered	HV	DCO	DCO	No. follow-up	Others	Total	%	No.	%
C01-02	Tongue	52	86.5	3.8	2	0	0	2	3.8	50	96.2
C03-06	Oral cavity	76	78.9	15.8	12	0	0	12	15.8	64	84.2
C07-08	Salivary gland	51	78.4	3.9	2	0	0	2	3.9	49	96.1
C09	Tonsil	27	85.2	0.0	0	0	0	0	0.0	27	100.0
C11	Nasopharynx	74	91.9	0.0	0	0	0	0	0.0	74	100.0
C12-13	Hypopharynx	51	78.4	0.0	0	0	0	0	0.0	51	100.0
C15	Oesophagus	347	75.2	12.1	42	1	0	43	12.4	304	87.6
C16	Stomach	4693	81.2	8.3	389	2	9	400	8.5	4293	91.5
C17	Small intestine	86	86.0	4.7	4	0	1	5	5.8	81	94.2
C18	Colon	1215	80.1	7.7	94	1	0	95	7.8	1120	92.2
C19-20	Rectum	1168	86.7	3.9	45	0	1	46	3.9	1122	96.1
C22	Liver	2672	20.9	12.7	339	1	4	344	12.9	2328	87.1
C23-24	Gall bladder	580	51.6	12.8	74	0	0	74	12.8	506	87.2
C25	Pancreas	625	32.8	17.1	107	0	0	107	17.1	518	82.9
C30-31	Nose/Sinuses	52	86.5	3.8	2	0	0	2	3.8	50	96.2
C32	Larynx	247	76.9	10.1	25	0	0	25	10.1	222	89.9
C33-34	Lung	2974	63.8	13.6	405	0	3	408	13.7	2566	86.3
C37-38	Other thoracic organs	66	66.7	13.6	9	1	0	10	15.2	56	84.8
C40-41	Bone	115	71.3	7.8	9	0	2	11	9.6	104	90.4
C43	Melanoma skin	45	95.6	0.0	0	0	0	0	0.0	45	100.0
C44	Other skin	276	89.1	4.3	12	0	0	12	4.3	264	95.7
C47+C49	Connective tissue	138	88.4	2.2	3	0	0	3	2.2	135	97.8
C48	Peritoneum	57	63.2	5.3	3	0	0	3	5.3	54	94.7
C50	Breast	1505	90.8	3.9	59	1	0	60	4.0	1445	96.0
C53	Cervix	1334	90.4	2.3	31	1	4	36	2.7	1298	97.3
C54	Corpus uteri	140	95.0	0.0	0	0	0	0	0.0	140	100.0
C55	Uterus unspecified	67	16.4	50.7	34	0	0	34	50.7	33	49.3
C56	Ovary	420	79.3	7.1	30	0	0	30	7.1	390	92.9
C61	Prostate	309	83.8	8.7	27	0	0	27	8.7	282	91.3
C62	Testis	29	89.7	0.0	0	0	0	0	0.0	29	100.0
C64	Kidney	292	72.3	4.5	13	0	0	13	4.5	279	95.5
C65	Renal pelvis	34	91.2	0.0	0	0	0	0	0.0	34	100.0
C66	Ureter	34	88.2	2.9	1	0	0	1	2.9	33	97.1
C67	Urinary bladder	508	81.1	8.1	41	0	0	41	8.1	467	91.9
C70-72	Brain & nervous system	386	57.3	13.5	52	0	1	53	13.7	333	86.3
C73	Thyroid	729	90.1	2.3	17	0	0	17	2.3	712	97.7
C74	Adrenal gland	32	71.9	6.3	2	0	0	2	6.3	30	93.8
C81	Hodgkin lymphoma	28	100.0	0.0	0	0	0	0	0.0	28	100.0
C82-85+C96	Non-Hodgkin lymphoma	488	98.6	0.0	0	0	5	5	1.0	483	99.0
C90	Multiple myeloma	89	95.5	0.0	0	0	0	0	0.0	89	100.0
C91	Lymphoid leukaemia	125	98.4	0.0	0	0	0	0	0.0	125	100.0
C92-94	Myeloid leukaemia	251	98.0	0.0	0	0	1	1	0.4	250	99.6

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Incheon, South Korea, 1997-2001 cases followed-up until 2002)
- Table2b:	Number and proportion of cases by vital status and median follow-up (in months) by site (Incheon, Korea, 1997-2001 cases followed-up until 2002)
- Table3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Incheon, South Korea, 1997-2001 cases followed-up until 2002)
- Table4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Incheon, South Korea, 1997-2001 cases followed-up until 2002)

Registry chapter:

Consult the chapter in Cancer survival in developping countries (Volume II)